hotspot -WSS

hotspot

author：focus 2025-08-12 11:29:22 - browse：4129

BRENDAN SMIALOWSKI/AFP via Getty Images

A New York jury on Wednesday convicted the former CEO of Stimwave, a company that sold devices with dummy pieces of plastic, on two counts of health care fraud. The maximum jail sentence for each count is 20 years.

Laura Perryman led Stimwave, which sold nerve stimulation devices to combat pain, from 2010 to 2019. Under her leadership, Stimwave distorted the design of the device to better fit insurance codes, resulting in unnecessary plastic components that allowed the company to sell its products for thousands of dollars more than it otherwise could. From 2017 to 2020, the company sold nearly 8,000 devices with the non-functioning component.

STAT published new details about the Stimwave story last May, after former employees described how Perryman broke into Stimwave’s Florida headquarters to steal back devices after her termination in 2019. The fraud laid bare the limits of the Food and Drug Administration’s device surveillance system, doctors’ ability to scrutinize device effectiveness, and how impossible it is for patients to get answers about the implants they receive.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Novavax promises a turnaround & Lilly roils the obesity market
Next article： With trial win, GSK could get blood cancer drug back on market

WSS

With trial win, GSK could get blood cancer drug back on market

Heat wave can put hearts into ‘oxygen debt,' lab experiment shows

At ASCO, pharma leaders speak of advances in 'smart bomb' drugs

'Essentially witchcraft:' A former naturopath takes on the field

The system is set up to fail children with medical complexity

See how much Covid

Wikipedia

hotspot

hotspot

Continuity nursing helped my family in our darkest PICU moments

At ASCO, pharma leaders speak of advances in 'smart bomb' drugs

What does generative AI mean for health care? We asked experts

At ASCO, pharma leaders speak of advances in 'smart bomb' drugs

BioMarin wins approval for gene therapy to treat hemophilia A

Heat wave can put hearts into ‘oxygen debt,' lab experiment shows

George Santos makes 1st court appearance after pleading not guilty to 13 counts

NIH documents show early flaws of $1.6 billion long Covid program

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

ASCO: AstraZeneca says CAR

leisure time

Lilly's Alzheimer's drug donanemab backed by FDA advisers

HIV drugs protect against transmission, even in unprotected sex

ASCO Daily Recap: Safety data from Novartis, survival from Pfizer

Readout LOUD podcast: ASCO preview, a Duchenne trial failure

How faith leaders like me can help address America's obesity epidemic

How to increase colonoscopy rates? Looks like an AI can help

explore

hotspot

explore

hotspot